Peter Sand to Adolescent
This is a "connection" page, showing publications Peter Sand has written about Adolescent.
Connection Strength
0.341
-
The reliability and validity of the revised Diabetes Family Conflict Scale questionnaire, in a sample of Swedish children. Acta Paediatr. 2013 Jun; 102(6):650-4.
Score: 0.044
-
The reliability of the Health Related Quality Of Life questionnaire PedsQL 3.0 Diabetes Module™ for Swedish children with type 1 diabetes. Acta Paediatr. 2012 Aug; 101(8):e344-9.
Score: 0.042
-
Impact of transdermal oxybutynin on work productivity in patients with overactive bladder: results from the MATRIX study. Pharmacoeconomics. 2009; 27(4):329-39.
Score: 0.033
-
Cystoscopy for lower urinary tract symptoms in urogynecologic practice: the likelihood of finding bladder cancer. Int Urogynecol J Pelvic Floor Dysfunct. 2008 Jul; 19(7):991-4.
Score: 0.031
-
Oxybutynin transdermal system improves the quality of life in adults with overactive bladder: a multicentre, community-based, randomized study. BJU Int. 2007 Apr; 99(4):836-44.
Score: 0.029
-
Delivery mode is a major environmental determinant of stress urinary incontinence: results of the Evanston-Northwestern Twin Sisters Study. Am J Obstet Gynecol. 2005 Dec; 193(6):2149-53.
Score: 0.027
-
Children Treated for Nonsyndromic Craniosynostosis Exhibit Average Adaptive Behavior Skills with Only Minor Shortcomings. Plast Reconstr Surg. 2021 02 01; 147(2):453-464.
Score: 0.019
-
The Cognitive Profile of Children with Nonsyndromic Craniosynostosis. Plast Reconstr Surg. 2019 05; 143(5):1037e-1052e.
Score: 0.017
-
Effect of a urinary control insert on quality of life in incontinent women. Int Urogynecol J Pelvic Floor Dysfunct. 1999; 10(2):100-5.
Score: 0.017
-
Enhanced interpretability of the PFDI-20 with establishment of reference scores among women in the general population. Neurourol Urodyn. 2012 Nov; 31(8):1252-7.
Score: 0.010
-
Nongenetic factors associated with stress urinary incontinence. Obstet Gynecol. 2011 Feb; 117(2 Pt 1):251-255.
Score: 0.010
-
Urge incontinence: estimating environmental and obstetrical risk factors using an identical twin study. Int Urogynecol J. 2010 Aug; 21(8):939-46.
Score: 0.009
-
Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study. J Urol. 2009 Apr; 181(4):1764-72.
Score: 0.008
-
Incontinence history as a predictor of detrusor stability. Obstet Gynecol. 1988 Feb; 71(2):257-60.
Score: 0.008
-
Supine urethroscopic and standing cystometry as screening methods for the detection of detrusor instability. Obstet Gynecol. 1987 Jul; 70(1):57-60.
Score: 0.007
-
Safety and tolerability of extended-release oxybutynin once daily in urinary incontinence: combined results from two phase 4 controlled clinical trials. Int Urol Nephrol. 2007; 39(4):1069-77.
Score: 0.007
-
Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT). Clin Ther. 2006 Nov; 28(11):1935-46.
Score: 0.007
-
Voiding dysfunction in the adolescent. Obstet Gynecol Surv. 1986 Jun; 41(6):342-7.
Score: 0.007
-
Effectiveness of a urinary control insert in the management of stress urinary incontinence: early results of a multicenter study. Urology. 1996 May; 47(5):629-36.
Score: 0.003
-
[Alcohol and drug abuse as risk factors for violence and delinquency in schizophrenic patients]. Psychiatr Prax. 1993 Sep; 20(5):172-5.
Score: 0.003
-
Conservative treatment of ectopic pregnancy with methotrexate. Am J Obstet Gynecol. 1986 Jun; 154(6):1299-306.
Score: 0.002
-
Pregnancy outcome subsequent to consecutive hydatidiform moles. Am J Obstet Gynecol. 1982 Apr 15; 142(8):1060-1.
Score: 0.001